acetaminophen aspirin and caffeine (21130-074)

Drug Facts

Product Profile

Brand Name acetaminophen aspirin and caffeine

Generic Name acetaminophen, aspirin and caffeine

Labeler better living brands, llc

Dosage Form TABLET, FILM COATED

Routes

ORAL

Active Ingredients

acetaminophen 250 mg/1, aspirin 250 mg/1, caffeine 65 mg/1

Manufacturer

Better Living Brands, LLC

Identifiers & Regulatory

Product NDC 21130-074

Product ID 21130-074_068e2ba0-2db2-4c12-ad9e-47a7130c2a22

Product Type HUMAN OTC DRUG

Marketing Category ANDA

Application Number ANDA211695

Listing Expiration 2026-12-31

Marketing Start 2023-08-11

Pharmacologic Class

Established (EPC)

nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc] central nervous system stimulant [epc] methylxanthine [epc]

Mechanism of Action

cyclooxygenase inhibitors [moa]

Chemical Structure

anti-inflammatory agents, non-steroidal [cs] xanthines [cs]

Physiologic Effect

decreased prostaglandin production [pe] decreased platelet aggregation [pe] central nervous system stimulation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 21130074

Hyphenated Format 21130-074

Supplemental Identifiers

RxCUI

308297

UNII

362O9ITL9D R16CO5Y76E 3G6A5W338E

NUI

N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832 N0000175739 N0000175729 N0000175790 M0023046

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acetaminophen aspirin and caffeine (source: ndc)

Generic Name acetaminophen, aspirin and caffeine (source: ndc)

Application Number ANDA211695 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

250 mg/1
65 mg/1

source: ndc

Packaging

1 BOTTLE in 1 CARTON (21130-074-07) / 24 TABLET, FILM COATED in 1 BOTTLE
1 BOTTLE in 1 CARTON (21130-074-14) / 50 TABLET, FILM COATED in 1 BOTTLE
1 BOTTLE in 1 CARTON (21130-074-21) / 100 TABLET, FILM COATED in 1 BOTTLE

source: ndc

Packages (3)

21130-074-07 1 BOTTLE in 1 CARTON (21130-074-07) / 24 TABLET, FILM COATED in 1 BOTTLE 21130-074-14 1 BOTTLE in 1 CARTON (21130-074-14) / 50 TABLET, FILM COATED in 1 BOTTLE 21130-074-21 1 BOTTLE in 1 CARTON (21130-074-21) / 100 TABLET, FILM COATED in 1 BOTTLE

Ingredients (3)

acetaminophen (250 mg/1) aspirin (250 mg/1) caffeine (65 mg/1)

Linked Drug Pages (1)

ACETAMINOPHEN ASPIRIN AND CAFFEINE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "068e2ba0-2db2-4c12-ad9e-47a7130c2a22", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["308297"], "spl_set_id": ["f8050cae-8619-f49b-e053-6294a90ad9e6"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Better Living Brands, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (21130-074-07)  / 24 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "21130-074-07", "marketing_start_date": "20230811"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (21130-074-14)  / 50 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "21130-074-14", "marketing_start_date": "20230811"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (21130-074-21)  / 100 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "21130-074-21", "marketing_start_date": "20230811"}], "brand_name": "ACETAMINOPHEN ASPIRIN AND CAFFEINE", "product_id": "21130-074_068e2ba0-2db2-4c12-ad9e-47a7130c2a22", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "21130-074", "generic_name": "acetaminophen, aspirin and caffeine", "labeler_name": "Better Living Brands, LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "ACETAMINOPHEN ASPIRIN AND CAFFEINE", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "ANDA211695", "marketing_category": "ANDA", "marketing_start_date": "20230811", "listing_expiration_date": "20261231"}